← All stocks

DiaMedica Therapeutics Inc.

DMAC Net buying
CIK 0001401040 #3414 in the set updated 18 Sep 2026
Bought (12 mo)
$7.63M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$7.63M
+$7.63M against sales at will

By person

9 insiders · 8 transactions
1.7×

Rick Pauls holds only 1.7 times base salary in stock. $1.10M of shares against $645.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Rick Pauls last reported holding, valued at $8.57, the price Common Shares was last bought or sold at on the open market here, on 25 Nov 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
STAHLBERG JAN
10% owner
$7.63M (7)
+$7.63M
8,825,742
16.37%
$75.68M
+69.0%
Von Koch Thomas
10% owner
8,383,577
15.55%
$71.89M
+51.7%
JACINTO RICHARD II
10% owner
4,958,823
9.20%
$42.52M
+8.8%
Giuffre Randall Michael
Director
398,587
0.7391%
$3.42M
+9.3%
Pilnik Richard D.
Director
312,995
0.5804%
$2.68M
+12.3%
Pauls Dietrich John
President & CEO
128,791
0.2388%
$1.10M
+87.8%
Parsons James T.
Director
97,949
0.1816%
$839.90K
+63.4%
Semba Charles Pauling
Director
47,963
0.0889%
$411.28K
+22.0%
Kuntz Richard
Director
24,210
0.0449%
$207.60K
+69.5%
Insider
Date
Role
Action
Shares
Price
Amount
STAHLBERG JAN
25 Nov 2025
10% owner
Buy indirect
73,099
$8.57
$626.82K
STAHLBERG JAN
24 Nov 2025
10% owner
Buy indirect
40,253
$7.89
$317.72K
Parsons James T.
21 Nov 2025
Director
Exercised, kept
12,000
$2.20
$26.40K
STAHLBERG JAN
21 Nov 2025
10% owner
Buy indirect
208,872
$7.41
$1.55M
STAHLBERG JAN
20 Nov 2025
10% owner
Buy indirect
128,426
$7.41
$951.21K
STAHLBERG JAN
19 Nov 2025
10% owner
Buy indirect
240,352
$7.21
$1.73M
STAHLBERG JAN
18 Nov 2025
10% owner
Buy indirect
182,882
$6.75
$1.23M
STAHLBERG JAN
17 Nov 2025
10% owner
Buy indirect
187,393
$6.52
$1.22M

What was left out

Form 4 filings counted 16
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 91,825
History held since 11 Dec 2018